| 1. |
Yin P, Wu JY, Wang LJ, et al. The burden of COPD in China and its provinces: findings from the Global Burden of Disease Study 2019. Front Public Health, 2022, 10: 859499.
|
| 2. |
葉志鵬, 陳磊. 慢性阻塞性肺疾病合并焦慮抑郁的研究進展. 中國呼吸與危重監護雜志, 2019, 18(5): 491-494.
|
| 3. |
Huang K, Huang KW, Xu JY, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease in China: Results from the China Pulmonary Health [CPH] Study. Int J Chron Obstruct Pulmon Dis, 2021, 16: 3387-3396.
|
| 4. |
柯彩霞, 成守珍, 梁秀, 等. COPD病人焦慮、抑郁狀況與社會支持的相關性研究. 全科護理, 2021, 19(12): 1684-1688.
|
| 5. |
留永健, 田欣倫, 郭兮恒, 等. 慢性阻塞性肺疾病合并焦慮抑郁患病調查. 中國呼吸與危重監護雜志, 2020, 19(5): 425-429.
|
| 6. |
Wrzeciono A, Czech O, Buchta K, et al. Assessment of stress, depressive and anxiety symptoms in patients with COPD during in-hospital pulmonary rehabilitation: an observational cohort study. Medicina (Kaunas), 2021, 57(3): 197.
|
| 7. |
Wu D, Zhao XN, Huang D, et al. Outcomes associated with comorbid anxiety and depression among patients with stable COPD: a patient registry study in China. J Affect Disord, 2022, 313: 77-83.
|
| 8. |
Hernández-Pérez A, Vargas-Nú?ez I, Moreno-Jiménez B, et al. Affective comorbidity associated with symptoms, lung function, and differences between patients with COPD for biomass and tobacco smoke exposure. J Clin Psychol Med Settings, 2022, 29(2): 310-317.
|
| 9. |
翟秋麗, 徐康, 李秀. 慢性阻塞性肺疾病患者合并焦慮的相關因素分析. 中國呼吸與危重監護雜志, 2020, 19(4): 393-397.
|
| 10. |
Yohannes AM, Murri MB, Hanania NA, et al. Depressive and anxiety symptoms in patients with COPD: a network analysis. Respir Med, 2022, 198: 106865.
|
| 11. |
方燕紅, 劉蘭芝. 慢性阻塞性肺疾病患者心理痛苦及相關影響因素. 中國健康心理學雜志, 2019, 27(9): 1370-1373.
|
| 12. |
Bülbülo?lu S, Kaplan Serin E. Effect of perceived dyspnea on attitude toward death from the perspective of COPD patients. Omega (Westport), 2023, 86(3): 913-929.
|
| 13. |
Bordoni B, Marelli F, Morabito B, et al. Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath. Monaldi Arch Chest Dis, 2017, 87(1): 811.
|
| 14. |
常旭. 慢阻肺合并焦慮、抑郁心理狀態患者的血清生物標志物檢驗結果分析. 心理月刊, 2021, 16(4): 31-32.
|
| 15. |
Strollo HC, Nouraie SM, Hoth KF, et al. Association of systemic inflammation with depressive symptoms in individuals with COPD. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2515-2522.
|
| 16. |
Milaneschi Y, Kappelmann N, Ye Z, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry, 2021, 26(12): 7393-7402.
|
| 17. |
Borroto-Escuela DO, Ambrogini P, Chru?cicka B, et al. The role of central serotonin neurons and 5-HT heteroreceptor complexes in the pathophysiology of depression: a historical perspective and future prospects. Int J Mol Sci, 2021, 22(4): 1927.
|
| 18. |
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology, 2021, 160(5): 1486-1501.
|
| 19. |
Bhatt S, Devadoss T, Manjula SN, et al. 5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol, 2021, 19(9): 1545-1559.
|
| 20. |
Bandelow B. Current and novel psychopharmacological drugs for anxiety disorders. Adv Exp Med Biol, 2020, 1191: 347-365.
|
| 21. |
Strawn JR, Levine A. Treatment response biomarkers in anxiety disorders: from neuroimaging to neuronally-derived extracellular vesicles and beyond. Biomark Neuropsychiatry, 2020, 3: 100024.
|
| 22. |
Kui HQ, Su HH, Wang Q, et al. Serum metabolomics study of anxiety disorder patients based on LC-MS. Clin Chim Acta, 2022, 533: 131-143.
|
| 23. |
李生霞. 心理護理干預對慢性阻塞性肺疾病伴呼吸衰竭患者的抑郁、焦慮緩解效果研究. 心理月刊, 2021, 16(4): 205-206.
|
| 24. |
Juruena MF, Eror F, Cleare AJ, et al. The role of early life stress in HPA axis and anxiety. Adv Exp Med Biol, 2020, 1191: 141-153.
|
| 25. |
Zhovanyk NV, Tovt-Korshynska MI. Interaction between clinical and psychological changes among patients with chronic obstructive pulmonary disease and pulmonary tuberculosis co-morbidity. Wiad Lek, 2019, 72(4): 635-638.
|
| 26. |
Aldhahi MI, Baattaiah BA, Nazer RI, et al. Impact of psychological factors on functional performance among patients with chronic obstructive pulmonary disease. Int J Environ Res Public Health, 2023, 20(2): 1285.
|
| 27. |
Fuentes-Alonso M, Lopez-Herranz M, López-de-Andrés A, et al. Prevalence and determinants of mental health among COPD patients in a population-based sample in Spain. J Clin Med, 2021, 10(13): 2786.
|
| 28. |
Wu DW, Chang LH, Yang PC, et al. Anxiety is a mediator between heart rate variability and quality of life in chronic obstructive pulmonary disease. J Pers Med, 2022, 12(6): 960.
|
| 29. |
Volpato E, Banfi P, Pagnini F. Promoting acceptance and adherence to noninvasive ventilation in chronic obstructive pulmonary disease: a randomized controlled trial. Psychosom Med, 2022, 84(4): 488-504.
|
| 30. |
Volpato E, Toniolo S, Pagnini F, et al. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2001-2021.
|
| 31. |
Lee SH, Lee H, Kim YS, et al. Predictors of low-level disease-specific knowledge in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2020, 15: 1103-1110.
|
| 32. |
吳小玲. 艾司西酞普蘭聯合綜合心理干預治療慢性阻塞性肺疾病合并焦慮抑郁療效觀察. 現代中西醫結合雜志, 2020, 29(14): 1522-1525.
|
| 33. |
屈蕾蕾, 胡杰亮, 劉麗君, 等. 帕羅西汀聯合坦度螺酮治療慢性阻塞性肺疾病合并焦慮與抑郁老年患者的臨床研究. 中國臨床藥理學雜志, 2021, 37(13): 1641-1644.
|
| 34. |
盧平, 歐立文, 李牛秀, 等. 氟哌噻噸美利曲辛片聯合沙美特羅替卡松治療慢性阻塞性肺疾病并焦慮抑郁癥的臨床療效及其對炎性因子的影響. 臨床合理用藥雜志, 2021, 14(9): 94-96.
|
| 35. |
Yang S, Xu Y, Peng WP, et al. Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Complement Ther Clin Pract, 2021, 45: 101470.
|
| 36. |
Fei F, J Siegert R, Zhang XH, et al. Symptom clusters, associated factors and health-related quality of life in patients with chronic obstructive pulmonary disease: a structural equation modelling analysis. J Clin Nurs, 2023, 32(1-2): 298-310.
|
| 37. |
Hart JL, Hong D, Summer A, et al. Stakeholders' views on reducing psychological distress in chronic obstructive pulmonary disease. J Pain Symptom Manage, 2022, 63(1): e21-e28.
|
| 38. |
Zhang XM, Yin CC, Tian WG, et al. Effects of cognitive behavioral therapy on anxiety and depression in patients with chronic obstructive pulmonary disease: a meta-analysis and systematic review. Clin Respir J, 2020, 14(10): 891-900.
|
| 39. |
Sohanpal R, Pinnock H, Steed L, et al. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials, 2020, 21(1): 18.
|
| 40. |
馮梅, 何穎, 袁敏, 等. 聚焦式心理干預在慢性阻塞性肺病(COPD)合并2型呼吸衰竭患者中的應用效果. 中國健康心理學雜志, 2023, 31(1): 53-58.
|
| 41. |
唐靜, 張凱莉, 崔君, 等. 健康教育對慢性阻塞性肺病患者情緒、不良認知及社會功能的影響. 國際精神病學雜志, 2020, 47(2): 393-395, 403.
|
| 42. |
張彩麗, 單海娟. 標準化心理干預對慢性阻塞性肺疾病患者自我感受負擔、負性情緒及生活質量的影響. 中國健康心理學雜志, 2021, 29(9): 1341-1344.
|
| 43. |
Zhang YT, Zhao XF. Effects of the health belief model-based intervention on anxiety, depression, and quality of life in chronic obstructive pulmonary disease. Neuroimmunomodulation, 2021, 28(3): 129-136.
|
| 44. |
Giusti EM, Papazian B, Manna C, et al. The effects of an acceptance and commitment-informed interdisciplinary rehabilitation program for chronic airway diseases on health status and psychological symptoms. Front Psychol, 2022, 12: 818659.
|
| 45. |
朱海敏, 陳冠彬, 劉業輝, 等. 歌唱療法作為慢性阻塞性肺疾病的康復手段在基層醫院中的應用. 內蒙古醫學雜志, 2020, 52(7): 807-809.
|
| 46. |
Lewis A, Philip KEJ, Lound A, et al. The physiology of singing and implications for 'Singing for Lung Health' as a therapy for individuals with chronic obstructive pulmonary disease. BMJ Open Respir Res, 2021, 8(1): e000996.
|
| 47. |
Huang J, Yuan XH, Zhang N, et al. Music therapy in adults with COPD. Respir Care, 2021, 66(3): 501-509.
|
| 48. |
沈菊鳳, 侯雪芬, 劉春霞. 中醫情志護理干預對心肌梗死患者心理狀態的影響. 新中醫, 2021, 53(17): 188-190.
|
1/5
WeChat